Zoom Logo

CELS VR Webinar Series: IP and Startup Valuations in Times of Crisis - Shared screen with speaker view
Nathaniel Butlin
13:27
WEBINAR05
Nathaniel Butlin
13:46
Free Individual or Start-Up (Bundled) Membership
Nathaniel Butlin
13:56
Please Join!
Hatim Chraibi
14:56
Welcome back Rahim
Hatim Chraibi
15:17
Hi Matt.
Hatim Chraibi
16:40
Nice to see you again Michael. Hope all is well and that Cohesys is thriving!!!
Hatim Chraibi
17:35
Thanks for sharing Bill.
Bill
19:23
Appreciate feedback.
Anton Neschadim
27:32
Great resource to leverage in licensing negotiations!
Richard Ayllon
29:39
Thanks for joing the CELS Webinar. Please submit questions to Efrat via this chat space
Bill
34:42
Filed full utility patent in US ~2.5 years and patent-pending. Possible to license or use prior to granting?
Hatim Chraibi
39:28
Can you expand further on why there are less than 8% healthcare unicorns? You mentioned something about funding without elaborating.
Hatim Chraibi
42:36
Welcome Pierre-Alexandre.
JL
46:52
Question: It's interesting to see the difference between software and healthcare companies. What are your thoughts regarding the best IP strategy for companies that build software as a medical device?
Hatim Chraibi
49:50
Thanks Nathan for sharing the offer code to join CELS. All, looking forward to your joining the organization.
Lalit GAUR
54:53
Theranos was a unicorn in life sciences, that fell to the ground....there is bad blood ...pun intended ;-)
Rahim - Fluid Biotech
55:06
Does the Foresight Valuation Group help companies value their company (based on IP etc) to substantiate a funding raise ?
Sedric Pankras
55:58
Question: Healthtech software that analyse Genome data for making treatment decision ---what patnet strategy you would recommend in the light of your discussion?
Bill
57:27
Question: Filed full utility patent in US ~2.5 years and patent-pending. Possible to license or use prior to granting?
Ehsan Daneshi
59:37
How to find opportunities for early licensing? How to start the negotiation with larger companies for licensing our IP and early-stage technology to them properly? Is there any service to help medical device startups on this?
Sedric Pankras
01:00:38
What approaches you recommend to value IP: NPV Vs Comparables ?
Bill
01:00:57
Question: Suggestions on strategy on how to get pending patent licensed?
Sedric Pankras
01:03:34
Question: What approaches you recommend to value IP: NPV Vs Comparables ? How you would use that for Structuring licensing deals for Lifescience Technologies?...……….asked the question earlier would be great to hear thought on the second part?
Rahim - Fluid Biotech
01:07:07
thank you all ! :) btw, i want one of Richard's shirts...from his closet he has plenty to share:)
Ikennah Browne
01:07:24
Excellent talk!! Thanks so much!
suddha
01:08:07
Excellent Talk ! Thanks Efrat
Ehsan Daneshi
01:08:17
Thank you!
Sedric Pankras
01:08:21
Thanks Efrat
suddha
01:08:28
Thank you Richard & Hatim
Bill
01:08:30
Thank you